Pfizer Limited — Results, 01-02-2025: Integrated Filing- Financial

Pfizer Limited has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. For this period, total income stood at ₹580.75 crore, while total expenses were ₹408.31 crore, resulting in a profit before tax of ₹172.44 crore. The company reported a net profit of ₹127.06 crore. The positive financial performance reflects effective cost management and operational efficiency which could enhance investor sentiment. However, completion of a pending asset transfer remains subject to MIDC approval, introducing a potential risk to future projections.